The store will not work correctly when cookies are disabled.
N-(3-(Aminomethyl)phenyl)-2-(naphthalen-1-yl)ethane-1-sulfonamide
ID: ALA4557555
PubChem CID: 155554728
Max Phase: Preclinical
Molecular Formula: C19H20N2O2S
Molecular Weight: 340.45
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: NCc1cccc(NS(=O)(=O)CCc2cccc3ccccc23)c1
Standard InChI: InChI=1S/C19H20N2O2S/c20-14-15-5-3-9-18(13-15)21-24(22,23)12-11-17-8-4-7-16-6-1-2-10-19(16)17/h1-10,13,21H,11-12,14,20H2
Standard InChI Key: RSFYIOZVBVSHSC-UHFFFAOYSA-N
Molfile:
RDKit 2D
24 26 0 0 0 0 0 0 0 0999 V2000
5.4645 -11.9937 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.8772 -12.7077 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
6.2897 -11.9912 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.3252 -13.9523 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0374 -14.3654 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7470 -13.9519 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7442 -13.1251 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4545 -12.7138 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1679 -13.1197 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5915 -13.1144 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.3019 -12.7033 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0110 -13.1111 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7209 -12.7007 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7184 -11.8785 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0002 -11.4685 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2932 -11.8854 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4299 -13.1071 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4324 -13.9284 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.3263 -13.1287 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0345 -12.7210 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0325 -11.9052 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3231 -11.4960 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.6142 -11.9128 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.6196 -12.7273 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
19 4 2 0
4 5 1 0
5 6 2 0
6 7 1 0
7 20 2 0
7 8 1 0
8 9 1 0
9 2 1 0
2 10 1 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 11 1 0
13 17 1 0
17 18 1 0
19 20 1 0
20 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 19 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 340.45 | Molecular Weight (Monoisotopic): 340.1245 | AlogP: 3.28 | #Rotatable Bonds: 6 |
Polar Surface Area: 72.19 | Molecular Species: BASE | HBA: 3 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 9.80 | CX Basic pKa: 8.86 | CX LogP: 2.26 | CX LogD: 1.06 |
Aromatic Rings: 3 | Heavy Atoms: 24 | QED Weighted: 0.72 | Np Likeness Score: -1.14 |
References
1. Sabbah M, Mendes V, Vistal RG, Dias DMG, Záhorszká M, Mikušová K, Korduláková J, Coyne AG, Blundell TL, Abell C.. (2020) Fragment-Based Design of Mycobacterium tuberculosis InhA Inhibitors., 63 (9): [PMID:32240584] [10.1021/acs.jmedchem.0c00007] |